Khong HT - Search Results

1

miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance.

Liu Z, Liu H, Desai S, Schmitt DC, Zhou M, Khong HT, Klos KS, McClellan S, Fodstad O, Tan M. Liu Z, et al. Among authors: khong ht. J Biol Chem. 2013 Feb 8;288(6):4334-45. doi: 10.1074/jbc.M112.419168. Epub 2012 Dec 19. J Biol Chem. 2013. PMID: 23255607 Free PMC article.

2

miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20.

Liu Z, Smith KR, Khong HT, Huang J, Ahn EE, Zhou M, Tan M. Liu Z, et al. Among authors: khong ht. Oncotarget. 2016 Nov 29;7(48):78667-78679. doi: 10.18632/oncotarget.12018. Oncotarget. 2016. PMID: 27637078 Free PMC article.

3

Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.

Zhao YH, Zhou M, Liu H, Ding Y, Khong HT, Yu D, Fodstad O, Tan M. Zhao YH, et al. Among authors: khong ht. Oncogene. 2009 Oct 22;28(42):3689-701. doi: 10.1038/onc.2009.229. Epub 2009 Aug 10. Oncogene. 2009. PMID: 19668225

4

Demethylating Agents in the Treatment of Cancer.

Howell PM, Liu Z, Khong HT. Howell PM, et al. Among authors: khong ht. Pharmaceuticals (Basel). 2010 Jul 2;3(7):2022-2044. doi: 10.3390/ph3072022. Pharmaceuticals (Basel). 2010. PMID: 27713340 Free PMC article. Review.

5

Immunotherapy of melanoma: a critical review of current concepts and future strategies.

Riker AI, Radfar S, Liu S, Wang Y, Khong HT. Riker AI, et al. Among authors: khong ht. Expert Opin Biol Ther. 2007 Mar;7(3):345-58. doi: 10.1517/14712598.7.3.345. Expert Opin Biol Ther. 2007. PMID: 17309326 Review.

6

Activated CD4+ T cells enhance radiation effect through the cooperation of interferon-gamma and TNF-alpha.

Wang Y, Radfar S, Khong HT. Wang Y, et al. Among authors: khong ht. BMC Cancer. 2010 Feb 23;10:60. doi: 10.1186/1471-2407-10-60. BMC Cancer. 2010. PMID: 20178622 Free PMC article.

7

Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.

Radfar S, Wang Y, Khong HT. Radfar S, et al. Among authors: khong ht. J Immunol. 2009 Nov 15;183(10):6800-7. doi: 10.4049/jimmunol.0901747. Epub 2009 Oct 21. J Immunol. 2009. PMID: 19846868

8

Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma.

Wang Y, Radfar S, Liu S, Riker AI, Khong HT. Wang Y, et al. Among authors: khong ht. BMC Med. 2010 Feb 17;8:14. doi: 10.1186/1741-7015-8-14. BMC Med. 2010. PMID: 20163701 Free PMC article.

9

A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.

Werner TL, Ray A, Lamb JG, VanBrocklin M, Hueftle K, Cohen AL, Beck AC, Buys SS, Dyess DL, Butler TW, Dumlao TL, Neumayer L, Khong HT. Werner TL, et al. Among authors: khong ht. Clin Breast Cancer. 2017 Nov;17(7):503-509. doi: 10.1016/j.clbc.2017.04.010. Epub 2017 Apr 29. Clin Breast Cancer. 2017. PMID: 28579139 Clinical Trial.

10

A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors.

Cohen AL, Ray A, Van Brocklin M, Burnett DM, Bowen RC, Dyess DL, Butler TW, Dumlao T, Khong HT. Cohen AL, et al. Among authors: khong ht. Oncotarget. 2016 Dec 26;8(32):52413-52419. doi: 10.18632/oncotarget.14183. eCollection 2017 Aug 8. Oncotarget. 2016. PMID: 28881739 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page